or
forgot password

    • cancer clinical trials in rochester, MN

    • Vaccine Therapy in Treating Patients With Stage IV Melanoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Melanoma (Skin)
    CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma
    North Central Cancer Treatment Group
    Rochester, Minnesota 55905
    Recurrent Mantle Cell Lymphoma
    Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Adult Primary Cholangiocellular Carcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Sarcoma
    Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Esophageal Cancer, Gastric Cancer
    A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer
    Pfizer Investigational Site
    Rochester, Minnesota 55905
    Colorectal Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms
    Chemoprevention of Oral Premalignant Lesions
    Pfizer Investigational Site
    Rochester, Minnesota 55905
    Precancerous Conditions
    A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Prostate Cancer
    Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Prostatic Neoplasms
    Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Kidney Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Colorectal Cancer
    Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Head and Neck Cancer
    Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Lung Cancer
    Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Osteoporosis, Prostate Cancer
    CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma
    Mayo Clinic
    Rochester, Minnesota 55905
    Multiple Myeloma
    Phase II Trial of Allovectin-7® for Metastatic Melanoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Melanoma, Metastatic Melanoma, Malignant Melanoma, Skin Cancer
    Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer, Neurotoxicity
    Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific
    Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Leukemia, Myelodysplastic Syndromes
    Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Head and Neck Cancer
    Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
    Mayo Clinic
    Rochester, Minnesota 55905
    Unspecified Adult Solid Tumor, Protocol Specific
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Carcinoma of Unknown Primary
    Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia
    Mayo Clinic
    Rochester, Minnesota 55905
    Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis
    Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Mayo Clinic
    Rochester, Minnesota 55905
    Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    National Lung Screening Trial (NLST) Screening
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Lung Cancer
    Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Pancreatic Cancer
    Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
    North Central Cancer Treatment Group
    Rochester, Minnesota 55905
    Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer
    Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Drug/Agent Toxicity by Tissue/Organ, Multiple Myeloma and Plasma Cell Neoplasm
    Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer
    North Central Cancer Treatment Group
    Rochester, Minnesota 55905
    Recurrent Small Cell Lung Cancer
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Neurofibromatosis Type 1, Precancerous Condition
    Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer, Osteoporosis
    Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Colorectal Cancer, Metastatic Cancer
    CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Multiple Myeloma
    Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Head and Neck Cancer, Oral Complications of Radiation Therapy, Radiation Toxicity
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Pancreatic Cancer
    Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Anemia, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Pancreatic Cancer
    MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Lymphoma
    Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer, Hot Flashes
    Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Melanoma (Skin)
    Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia
    Mayo Clinic
    Rochester, Minnesota 55905
    Waldenström Macroglobulinemia
    Intrathecal Mafosfamide
    Mayo Clinic
    Rochester, Minnesota 55905
    Malignant Meningeal Neoplasms
    Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
    Mayo Clinic
    Rochester, Minnesota 55905
    Myelodysplastic Syndromes
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Metastatic Cancer, Sarcoma